Viyash Scientific to Acquire Italy’s BioForLife for Rs 188 Cr to Expand Global Pet Care Business
Hyderabad, June 8 (TNT): Hyderabad-based Viyash Scientific Limited, through its wholly owned subsidiary Alivira Animal Health Limited, has signed a binding agreement to acquire 100 per cent stake in Italy-based pet care company BioForLife (BFL) for a cash consideration of ₹188 crore.
The acquisition, expected to be completed in the second quarter of FY27, marks a significant step in Viyash Scientific’s strategy to tap the fast-growing global companion animal health generics market, the company said in a statement on Monday.
Based in Milan, BioForLife specializes in the development, commercialization and distribution of pet care products. The company has established a strong presence in nutritional supplements, pharmaceuticals and rapid diagnostic tests, while also expanding into fast-growing segments such as dermatology and ophthalmology.
The acquisition will strengthen Alivira’s companion animal health business globally and enhance its presence in the European pet care market.
Italy is among the five largest animal health markets in Europe, with companion animal care emerging as one of the fastest-growing segments due to rising pet ownership, increasing pet humanisation trends and higher spending on preventive and specialized veterinary care.
BioForLife has a well-established sales network that reaches more than 80 per cent of veterinary clinics in Italy, providing strong customer relationships and a platform for future growth.
Viyash Scientific said the acquisition will create opportunities to introduce products from Alivira’s pipeline into the Italian market, while also enabling the expansion of BioForLife’s product portfolio across Alivira’s operations in Europe, the Middle East, Asia and Latin America.
Commenting on the acquisition, Dr. Haribabu Bodeputi, Managing Director and Group CEO of Viyash Scientific Limited, said the deal represents an important step in the company’s strategy to build a leading global companion animal health business.
“BioForLife provides us with an established platform in Italy, one of Europe’s most attractive pet care markets, while strengthening our presence across the region. The combination of BioForLife’s commercial reach and Alivira’s product development capabilities creates a compelling opportunity to accelerate growth and expand our companion animal portfolio,” he said.
He added that the company also sees significant opportunities to introduce innovative products into India and other geographies through its global network.
The transaction will further strengthen Alivira’s management team, with BioForLife executives continuing to lead business operations and drive future growth initiatives.
The acquisition builds on Alivira’s track record of international expansion, having acquired and integrated several animal health companies across Europe, Latin America and Asia over the past decade.
TNT TS
